<DOC>
	<DOCNO>NCT00899821</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn interleukin-2 , interleukin-12 , GM-CSF deliver microspheres increase body 's ability kill tumor cell . PURPOSE : This laboratory study look microsphere-delivered cytokine see increase tumor response lymphocytes patient head neck cancer .</brief_summary>
	<brief_title>Microsphere-Delivered Cytokines Increasing Tumor Response Lymphocytes From Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether local sustain delivery cytokine ( interleukin-2 , interleukin-12 , sargramostim [ GM-CSF ] ) biodegradable microspheres augments antitumor response human peripheral blood lymphocyte ( PBLs ) obtain patient squamous cell carcinoma head neck , evaluate human/SCID chimeric mouse model . - Assess potential cytokine-loaded microspheres combine dendritic cell ( pulsed tumor peptide ) obtain patient enhance long-term immunity tumor , evaluate human/SCID chimeric mouse model . - Evaluate antitumor effect effective approach ( objective I II ) establish tumor mouse model . OUTLINE : Biopsies tumor obtained surgical resection . Patients undergo phlebotomy leukapheresis obtain peripheral blood lymphocyte ( PBLs ) . PBLs , tumor tissue , cytokine-loaded microspheres coengrafted SCID mouse . Tumor growth immune response determine . Dendritic cell obtain PBLs , expand culture , pulse either autologous tumor cell lysates peptide eluted tumor cell . The dendritic cell coengrafted tumor cell , PBLs , cytokine-loaded microspheres SCID mouse . The mouse challenge autologous tumor cell , antitumor response determine . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Interleukin-12</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck Tumor tissue show engraftment severe combine immunodeficient ( SCID ) mouse growth tissue culture PATIENT CHARACTERISTICS : Age 20 80 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant nursing Fertile patient must use effective contraception No known immunocompromised disease condition No social , physical , psychiatric condition would preclude leukapheresis PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other No concurrent immunosuppressive medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>